These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32876952)

  • 21. The impact of SARS-CoV-2 variants on IBD management.
    Segal JP; Kumar A; Raine T; Lamb CA; Brookes MJ
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):343-344. PubMed ID: 33711289
    [No Abstract]   [Full Text] [Related]  

  • 22. Review of inflammatory bowel disease and COVID-19.
    Sultan K; Mone A; Durbin L; Khuwaja S; Swaminath A
    World J Gastroenterol; 2020 Oct; 26(37):5534-5542. PubMed ID: 33088153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease.
    Martin-Arranz MD; García-Ramírez L; Hernandez-Perez M; Montero Vega D; Martín-Arranz E; Sánchez-Azofra M; Poza Cordon J; Rueda Garcia JL; Noci Belda J; Verges Martínez-Meco T; Blanco San Miguel P; Suarez Ferrer C
    Sci Rep; 2023 Apr; 13(1):7044. PubMed ID: 37120662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic.
    Vadan R; Iacob R; Costache R; Stroie T; Saizu IA; Iacob S; Gheorghe L; Diculescu M; Gheorghe C
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):549-553. PubMed ID: 33331349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence.
    Kumric M; Ticinovic Kurir T; Martinovic D; Zivkovic PM; Bozic J
    World J Gastroenterol; 2021 Jul; 27(25):3748-3761. PubMed ID: 34321841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area.
    Axelrad JE; Malter L; Hong S; Chang S; Bosworth B; Hudesman D
    Inflamm Bowel Dis; 2021 Apr; 27(5):662-666. PubMed ID: 32578843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Singh AK; Jena A; Kumar-M P; Sharma V; Sebastian S
    United European Gastroenterol J; 2021 Mar; 9(2):159-176. PubMed ID: 33210980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
    Saibeni S; Scucchi L; Dragoni G; Bezzio C; Miranda A; Ribaldone DG; Bertani A; Bossa F; Allocca M; Buda A; Mocci G; Soriano A; Mazzuoli S; Bertani L; Baccini F; Loddo E; Privitera AC; Sartini A; Viscido A; Grossi L; Casini V; Gerardi V; Ascolani M; Ruscio MD; Casella G; Savarino E; Stradella D; Pumpo R; Cortelezzi CC; Daperno M; Ciardo V; Nardone OM; Caprioli F; Vitale G; Cappello M; Comberlato M; Alvisi P; Festa S; Campigotto M; Bodini G; Balestrieri P; Viola A; Pugliese D; Armuzzi A; Fantini MC; Fiorino G;
    United European Gastroenterol J; 2020 Dec; 8(10):1228-1235. PubMed ID: 33070758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
    Scribano ML
    Dig Dis Sci; 2021 Sep; 66(9):2855-2864. PubMed ID: 33073335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease.
    De Nicolò A; Cusato J; Bezzio C; Saibeni S; Vernero M; Disabato M; Caviglia GP; Ianniello A; Manca A; D'Avolio A; Ribaldone DG
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel.
    Hansen R; Meade S; Beattie RM; Auth MK; Croft N; Davies P; Devadason D; Doherty C; Epstein J; Howarth L; Kiparissi F; Muhammed R; Shivamurthy V; Spray C; Stanton MP; Torrente F; Urs A; Wilson D; Irving PM; Samaan M; Kammermeier J
    Gut; 2021 Jun; 70(6):1044-1052. PubMed ID: 32873696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
    Tepasse PR; Vollenberg R; Nowacki TM
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A surgically relevant summary of the addendum to the S3 guidelines of the DGVS on Crohn's disease and ulcerative colitis : Treatment of chronic inflammatory bowel diseases in the COVID-19 pandemic].
    Grunert PC; Dignass A; Kucharzik T; Stallmach A; Sturm A; Schmidt C
    Chirurg; 2021 Jan; 92(1):30-33. PubMed ID: 33320280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
    Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
    Caldera F; Balzora S; Hayney MS; Farraye FA; Cross RK
    Inflamm Bowel Dis; 2021 Oct; 27(10):1703-1705. PubMed ID: 34013958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study.
    Singh S; Khan A; Chowdhry M; Bilal M; Kochhar GS; Clarke K
    Gastroenterology; 2020 Oct; 159(4):1575-1578.e4. PubMed ID: 32522507
    [No Abstract]   [Full Text] [Related]  

  • 39. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Goodsall TM; Han S; Bryant RV
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1550-1555. PubMed ID: 33063927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease.
    Sebastian S; Gonzalez HA; Peyrin-Biroulet L
    J Crohns Colitis; 2020 Nov; 14(11):1632-1643. PubMed ID: 32520312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.